These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2448971)

  • 1. [Relations between atypical hyperplasia, dysplasia and prostatic cancer and the significance of its appearance for the clinician].
    Hoffmann L; Putzke HP; Günther I; Rodewald P; Erdmann T
    Z Urol Nephrol; 1987 Oct; 80(10):561-9. PubMed ID: 2448971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems of so-called atypical hyperplasia of the prostate].
    Mehlhorn J
    Z Urol Nephrol; 1987 Jul; 80(7):379-85. PubMed ID: 2444040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of prostate carcinoma. Diagnosis and differential diagnosis.
    Dhom G
    Pathol Res Pract; 1985 Jan; 179(3):277-303. PubMed ID: 2580293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in prostate pathology: dysplasia and carcinoma in situ.
    Epstein JI
    Monogr Pathol; 1992; (34):149-82. PubMed ID: 1406740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent prostatic carcinomas found at autopsy in men over 90 years old.
    Takahashi S; Shirai T; Hasegawa R; Imaida K; Ito N
    Jpn J Clin Oncol; 1992 Apr; 22(2):117-21. PubMed ID: 1377758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate].
    Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A
    Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small-acinar carcinoma.
    Srigley JR
    Semin Diagn Pathol; 1988 Aug; 5(3):254-72. PubMed ID: 2459751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency and differential diagnosis of cribriform structures of the prostate].
    Mehlhorn J
    Zentralbl Pathol; 1991; 137(4):349-54. PubMed ID: 1722706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical hyperplasia of the prostate: coincidence with invasive carcinoma. A study of 69 prostatectomy preparations].
    Garske U; Bittinger A; Weingärtner K; Neumann K
    Verh Dtsch Ges Pathol; 1993; 77():78-81. PubMed ID: 7511307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate gland-transition zone lesions. Etiology, growth regulation, growth factors, genetic changes].
    Pavelić J; Zeljko Z
    Lijec Vjesn; 2002; 124(6-7):211-9. PubMed ID: 19658339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between dysplastic lesions and latent cancers of the prostate. An analysis of 100 autopsies].
    Schütze U
    Z Urol Nephrol; 1984 Sep; 77(9):529-35. PubMed ID: 6209871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytological diagnosis of nodular hyperplasia and cancer of the prostate].
    Mel'nik AN; Goĭkhberg MI; Klimanko IA; Levitskiĭ EO
    Vopr Onkol; 1983; 29(1):40-3. PubMed ID: 6186085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign hyperplasia of the prostate--an autopsy analysis].
    Mehlhorn J
    Z Urol Nephrol; 1987 Jun; 80(6):323-8. PubMed ID: 2442920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic "dysplasia/atypical hyperplasia". Terminology, histopathology, pathobiology, and significance.
    Kastendieck H; Helpap B
    Urology; 1989 Dec; 34(6 Suppl):28-42. PubMed ID: 2481361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.